PFE
PfizerBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
PFE vs peer average
50/100
PFE vs. peer average (B vs. B)
Grade spread
A 3 · B 4 · C 1 · D 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biopharma peer with a broad commercial base and pipeline; relevant for comparing post-LOE portfolio replacement and capital allocation discipline.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PFE
Pfizer
AMGN
Amgen
Grade
B
D
Momentum
89
93
Value
63
61
Sentiment
53
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
PFE / AMGN
Grade Position
In line
PFE vs. peer average (B vs. B)
50/100
Momentum
89
AMGNValue
63
PFESentiment
53
PFERotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PFE
AMGN is the first peer returned for this comparison set.